To examine the effect of low DAB2IP expression on the global transcriptome of all ER+ breast tumors, we performed differential expression analysis, comparing the highest and lowest quartiles of DAB2IP expression among nonbasal ER+ tumors across all subtypes (n = 320). Here, DAB2IP is linked to breast neoplasm.